ArticleLeukemia2022
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP.
Julia Driessen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papertrialcites it